Super Micro Computer (SMCI) ended the recent trading session at $30.78, demonstrating a -2.9% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain ...
Journey Medical offers a rare microcap biopharma setup with a stable, cash-generating dermatology portfolio and a high-upside new drug, Emrosi. DERM’s commercial infrastructure enables rapid Emrosi ...
Centrus Energy stock could prove central to President Trump's Project Vault. As CNBC clarifies this morning, "the Trump administration's Project Vault stockpile can include any of the more than 50 ...
Super Micro Computer (SMCI) stock has surged about 15% over the past week, reflecting renewed trader interest in this AI server player. Yesterday, the company announced it will report fiscal Q2 2026 ...
Waste Management is rated Buy, with risk-reward attractive as headwinds fade and valuation sits below historical and peer levels. WM's organic growth should accelerate in 2026, driven by industrial ...
If you’re anything like me, you’ve likely learned to approach new beauty launches with a healthy dose of skepticism—especially those that promise overnight results or claim to replicate pricey ...
The Securities and Exchange Comission is pushing back against a growing market for “tokenized stocks” that look like equity, trade like equity, but do not actually confer ownership, releasing new ...
An international team of researchers, led by the University of Queensland and Imperial College London, has proposed a new framework for scientists detecting and measuring microplastics in the human ...
Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...
A new artificial-intelligence project at Google could disrupt how videogames are made. But AppLovin’s role in the mobile-gaming ecosystem remains intact, according to Benchmark Equity Research. The ...
There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results